OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	68
Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies	47
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	46
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	44
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	24
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	24
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	23
Deficits in our understanding of natural killer cell development in mouse and human	23
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy	19
Mechanisms of immunothrombosis in COVID-19	18
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	18
Regulation and importance of factor VIII levels in hemophilia A carriers	17
Disparities in acute myeloid leukemia treatments and outcomes	17
Developmental regulation of primitive erythropoiesis	16
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	16
The new world: hematopoietic stem cell transplant during a pandemic	15
The impact of obesity-induced inflammation on clonal hematopoiesis	15
Congenital neutropenia: disease models guiding new treatment strategies	15
Unraveling lipid metabolism for acute myeloid leukemia therapy	14
Platelet lifespan and mechanisms for clearance	14
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications	13
Editorial introductions	12
Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia	12
Editorial introductions	11
Significance and management of isolated distal deep vein thrombosis	11

Editorial introduction	11
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	10
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	10
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies	10
Thrombosis in myeloproliferative neoplasms: update in pathophysiology	9
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	9
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	9
Editorial introductions	9
Understanding and targeting erythroid progenitor cells for effective cancer therapy	9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	9
Red blood cell changes due to cancer and cancer treatments: a narrative review	8
Current Opinion in Hematology	8
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	8
The immunology of PF4 polyanion interactions	7
Modelling arterial thrombus formation in vitro	7
Modeling genetic platelet disorders with human pluripotent stem cells: mega-progress but wanting more on our plate(let)	7
Translation defects in ribosomopathies	7
Editorial introductions	7
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	7
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	7
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	6
Chediak-Higashi syndrome	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	6
The fulfilled promise and unmet potential of umbilical cord blood	6
Models to study myelodysplastic syndrome and acute myeloid leukaemia	6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	6
Editorial introduction	6
Platelet mitochondria: the mighty few	6
Editorial introductions	5
Platelet transfusion	5
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications	5
The state of prediction models in hematologic disease: a worrisome assessment	5
Novel approaches to measure transfusion effectiveness	5
Immunomodulatory roles of red blood cells	5
Azacitidine maintenance in AML post induction and posttransplant	4
Editorial introduction	4
Donor selection in allogeneic stem cell transplantation	4
Macrocytic anemias	4
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices	4
The congenital dyserythropoieitic anemias: genetics and pathophysiology	4
Editorial introduction	4
Prothrombotic state associated with preeclampsia	4
Epigenetics of hematopoietic stem cell aging	4
Recent advances in factor XII structure and function	4
Switching and increasing prophylaxis regimen with a genetically recombinant fusion of coagulation factor IX and albumin in haemophilia B: a case report	4
Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis	4
Red cell extracellular vesicles and coagulation activation pathways	4
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance	3
Age-related micro-environmental changes as drivers of clonal hematopoiesis	3
Pediatric acute myeloid leukemia – novel approaches	3

Iron status of blood donors	3
Hematopoietic stem cell collection for sickle cell disease gene therapy	3
The impact of prenatal inflammation on hematopoietic development	3
Detecting and preventing post-hematopoietic cell transplant relapse in AML	3
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island	3
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding	3
Brothers in arms: platelets and neutrophils in ischemic stroke	3
Scoring systems to predict thrombotic complications in solid tumor patients	3
Editorial introduction	2
N6-methyladenosine in hematological malignancies: a concise review	2
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease	2
Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients	2
Factor XI as a therapeutic target in neuroinflammatory disease	2
Editorial Introductions	2
The role of hematopoiesis in bone repair: an update	2
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms	2
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease	2
Direct megakaryopoiesis	2
Clonal hematopoiesis of indeterminate potential: recent developments and perspectives	2
Histological differences among thrombi in thrombotic diseases	2
Immunologic effects of red blood cell and platelet transfusions in neonates	2
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases	2
Circulating platelet count and glycans	2
The interplay between physical and mental health and its impact on outcomes for hemopoietic stem cell transplant patients	2
PIEZO1, sensing the touch during erythropoiesis	2
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia	2